[Proceedings: Therapeutic possibilities of deshydroepiandrosterone in faetal hypotrophy (author's transl)].
The therapeutic effect of DHEA-S has been studied in 15 cases of intra-uterine growth retardation. This double-blind study has not been able to demonstrate any difference between the effect DHEA-S and of NaCl on oestriol excretion, HPL values, and biparietal diameter. Only the uterine growth seems to be affected by DHEA-S. Thus it can be concluded that DHEA-S has no therapeutic effect on placental insufficiency.
D002986:Clinical Trials as Topic; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000502:physiology*; D006801:Humans; D010922:Placenta Diseases / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy
D003687:Dehydroepiandrosterone
Possibilités thérapeutiques du sulfate de déhydroépiandrostérone dans l'hypotrophie foetale